This post was originally published by Cure Specific disease characteristics of, and treatments for, multiple myeloma were not associated with...
Myeloma NZ
Exploring the Future of CAR T-Cell Therapy in Multiple Myeloma
This post was originally published by Targeted Oncology C. Ola Landgren, MD, PhD, chief of Myeloma Service and hematologic oncologist at...
Novel Agents Rouse Responses in Relapsed/Refractory Multiple Myeloma
This article was originally published by OncLive In just the past 5 years, incredible progress has been made in multiple myeloma, evidenced by the...
Despite COVID-19 limitations, fundraiser for multiple myeloma finds a way
This article was originally published on CBC 'We still had that sense of community happening out there anyway' Small but mighty groups of those with...
NICE turns down Celgene’s Revlimid as multiple myeloma maintenance treatment
This article originally published by PharmaTimes Online The National Institute for Heath and Care Excellence (NICE) has turned down NHS funding of...
Blood Cancer Awareness Month
This September, the International Myeloma Foundation (IMF) asks you to take part in a social media campaign to raise awareness about blood cancers,...
Daratumumab gets PBS listing recommendation after ‘disgraceful’ delay
This article was originally published by The Limbic The anti-CD38 mAb daratumumab (Darzalex) has received a positive recommendation from the...
Newsletter: Spring 2020
Hello Everybody It is hard to believe that we are nearly two thirds through the year and what a year it has been. The COVID-19 pandemic has impacted...
Learning About Resources in Multiple Myeloma
This article was originally published by Cure Understanding Smoldering Multiple Myeloma Transcript: Kristie L. Kahl: Can you explain what...
Changing Patterns of Care in Multiple Myeloma
This article was originally published by AJMC Treatment Evolution in Multiple Myeloma Looking at the current state of multiple myeloma management,...
FDA Approves Daratumumab, Carfilzomib, Dexamethasone Triplet to Treat Multiple Myeloma
This article was originally published by Cancer Network The FDA has approved daratumumab (Darzalex) for use in combination with carfilzomib...
Berdeja Compares Later-Line Therapies in Multiple Myeloma
This article was originally published by Targeted Oncology As part of a virtual Case Based Peer Perspective event, Jesus G. Berdeja, MC, director of...